Related Topics News - Drugs

     
 < Previous page   Title only   |   Print    Next page > 
     
《大行》瑞銀對醫療健康股投資評級及目標價(表)

2026-02-27T  
《大行》華泰證券指聯邦製藥UBT251 II期數據驚艷催化全球潛力 維持「買入」評級

2026-02-27T  
《大行》大華繼顯:AI創新及國策推動內地互聯網醫療領域 看好阿里健康及平安好醫生

2026-02-13T  
聯邦制藥羅紅霉素膠囊通過一致性評價

2026-02-09T  
《輪動華泰》阿里分拆平頭哥上市 情人節盲盒獲炒泡瑪升

2026-01-23T  
微創醫療漲近8% 發盈喜料去年扭虧為盈

2026-01-23T  
《盈喜》微創醫療預告扭虧 去年最少賺2,000萬美元

2026-01-22T  
《大行》花旗重新覆蓋微創醫療籲「買入」 目標價16元

2026-01-08T  
微創醫療終止合併微創腦科學

2025-12-31T  
微創腦科學委任張劼為主席

2025-11-17T  
 < Previous page    Next page > 

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.